FindTrial
Sign In

A randomized study of GnRHa therapy after laparoscopic myomectomy in reproductive women with uterine leiomyomas

A randomized study of GnRHa therapy after laparoscopic myomectomy in reproductive women with uterine leiomyomas

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014358
Enrollment
Unknown
Registered
2018-01-08
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine leiomyoma

Interventions

treatment group:GnRHa was used after surgery
control group:observation only after surgery

Sponsors

Shandong Provincial Qianfoshan Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patient's aged 18 to 45 years old; Uterine size is more than 10 gestation weeks and less than 20 gestation weeks; If the uterine size is less than 10 gestation size there must be symptoms such as menorrhagia, dysmenorrhea, pelvic mass,anemia, infertility and the size of largest myoma =5cm.

Exclusion criteria

Exclusion criteria: Submucosal myoma;Determined or suspicious malignant desease; Combined with adenomyosis or endometriosis;Have used GnRHa 3 months before surgery; Pregnancy and puerperium; Patient with contraindication;Allergic with GnRHa.

Design outcomes

Primary

MeasureTime frame
recurrence rate of myoma;—

Countries

China

Contacts

Public ContactLi Yan

Shandong Provincial Qianfoshan Hospital

yanliqy@163.com+86 13573126316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026